Key Highlights: Implications: PrecisionCHD taps India’s $1.5B+ cardiac diagnostics market (15% CAGR), challenging ECG/stress tests via molecular insights and Dr Lal’s netw...
Key Highlights: Implications: Kashiv’s scaling challenges Biocon/Serum Institute dominance in India’s $15B+ biologics CDMO space (18% CAGR), capturing 10-15% complex...
Key Highlights: Implications: The CDSCO approval gives India access to a new category of portable, AI-enabled MRI, which can begin to address the structural gap between neuroimaging ...
Mango Sciences Inc. Partners with ImmunoAdoptive Cell Therapy to Improve Access to NexCAR19 in India
Key Highlights: Implication: This financing model slashes NexCAR19’s effective cost by 30-40%, challenging global CAR-T players like Novartis/Kite while accelerating adoption in Tier...
Key Highlights: Implications: The large-scale Daisy Petal deployment at Serum Institute signals a meaningful shift from traditional fed-batch to perfusion-based biomanufacturing in v...
Key Highlights: Implications: The open call positions TeamBest and its partner foundations as influential collaborators in shaping AROI’s scientific agenda, which could accelerate th...
Key Highlights: Implications: India-specific models target the $1.68B cardiovascular devices/diagnostics market (8.5% CAGR to $2.53B by 2031), shifting Narayana’s 60K+ annual procedu...
Key Highlights: Implications: Dream Sock storms India’s connected parenting market, handing anxious new moms clinical-grade reassurance that traditional monitors can’...
Key Highlights: Implications: xStep revolutionizes neurorehabilitation by bringing hospital-grade spinal stimulation into patients’ homes, exploding access for s...
Key Highlights: Implications: TRIA disrupts India’s heart valve market by eliminating lifelong blood thinners, handing cardiothoracic surgeons a patient-friendly alte...









